Press Release for the quarter ended June 30, 2026.

Kaya Limited August 03, 2026 BSE Limited National Stock Exchange of India Limited Market Operations Department, 'Exchange Plaza', 5th Floor, 1st Floor, Phiroze Jeejeebhoy Towers, Plot No. C/1, G Block, Dalal Street, Bandra Kurla Complex, Mumbai – 400001 Bandra(E), Mumbai 400051 BSE Scrip Code: 539276 NSE Symbol: KAYA Subject: Media Release –Q1FY27 Dear Sir/ Madam, Please find enclosed a media release by Kaya Limited for the quarter ended June 30, 2026. This is for your information and records. For Kaya Limited, Brijesh Goyal Chief Financial Officer Encl: A/a Registered Office: Kaya Limited, Marks, 23/C, Mahal Industries Estate, Mahakali Caves Road, Near Paper Box Lane, Andheri (E), Mumbai 400 093. Tel.:91-22-66195000. Website: www.kaya.in CIN: L85190MH2003PLC139763 Kaya Limited announces Clinic business growth of 16% in Revenue over Q1 FY26 Mumbai, August 3rd, 2026: Kaya Limited (the “Company”), today announced its financial results for the quarter ended Jun 30th, 2026. Q1 FY27 Business Update Clinic business registered a growth of 16% in Revenue over Q1 FY26. • Services business registered revenue growth of 16% over Q1 FY26 mainly driven by categories like Brightening & Pigmentation, Acne & Scars, and Anti- Aging. • Skin business witnessed a growth of 19% over Q1 FY26. • Hair business has also shown a 17% growth over Q1 FY26 • Product business registered a growth of 16% over Q1 FY26. Mainly driven by categories like Nutraceutical, Lighter and Brighter and Anti-Aging. Financial Results • Revenue from operations is at ₹ 60.1 crs for Q1 FY27, a growth of 14% over the corresponding quarter Q1 FY26. • The Profit/(Loss) after tax for Q1 FY27 was at ₹ (15.2) crs, compared to Profit/(loss) after tax PAT of ₹ (14.2) crs in Q1 FY26. The higher loss was primarily driven by the impact of GST 2.0 changes effective September 2025, which restricted input tax credit availability. About Kaya Kaya (BSE: 539276, NSE: “KAYA”) leads the aesthetic revolution in India—driven by medical precision, ethical conviction, and disruptive innovation. In its 20 years+ legacy, Kaya has shaped the aesthetic dermatology space with its 600+ service lines; 75+ product mix; 100+ dermatologists and a commanding presence across 82 clinics pan-India. Kaya’s commitment is simple: deliver real results through honest methods. The leading chain operates with medical integrity at its core, blending science and artistry to create personalized experiences that inspire trust and transformation. Its strength lies in its people—driven professionals who embody values of care, curiosity, and excellence. Their dedication fuels Kaya’s reputation as a reliable, high-performing organization with consistently strong feedback from both customers and employees. Kaya believes in creating the future, not waiting for it. Whether it’s bringing the latest global technologies to India or building systems that scale with precision, Kaya stays ahead—by design. Disclaimer Statements in this press release describing the Company's performance may be "forward looking Statements” within the meaning of applicable securities laws and regulation. Actual results may differ materially from those directly or indirectly expressed, inferred, or implied. Important factors that could make a difference to the Company's operations include, among others, economic conditions affecting demand / supply and price conditions in the domestic markets in which the Company operates, changes in or due to the environment, Government regulations, laws, statutes, judicial pronouncements and / or other incidental factors. For more information visit www.kaya.in Kaya Limited, Regd. Off: 23/C, Mahal Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai 400093. Tel: (91-22) 66195000 # Website: www.kaya.in # Email: investorrelations@kayaindia.net